vs
Side-by-side financial comparison of Brookfield Infrastructure Corp (BIPC) and BioNTech SE (BNTX). Click either name above to swap in a different company.
BioNTech SE is the larger business by last-quarter revenue ($1.5B vs $866.0M, roughly 1.8× Brookfield Infrastructure Corp). BioNTech SE runs the higher net margin — -1.9% vs -35.7%, a 33.8% gap on every dollar of revenue.
Brookfield Infrastructure Partners L.P. is a publicly traded limited partnership with corporate headquarters in Toronto, Canada, that engages in the acquisition and management of infrastructure assets on a global basis.
BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
BIPC vs BNTX — Head-to-Head
Income Statement — Q2 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $866.0M | $1.5B |
| Net Profit | $-309.0M | $-28.7M |
| Gross Margin | 65.0% | — |
| Operating Margin | 62.7% | -3.1% |
| Net Margin | -35.7% | -1.9% |
| Revenue YoY | -4.6% | — |
| Net Profit YoY | -148.1% | — |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | — | $1.5B | ||
| Q2 25 | $866.0M | $260.8M | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | $908.0M | — | ||
| Q2 23 | $538.0M | — | ||
| Q2 22 | $479.0M | — |
| Q3 25 | — | $-28.7M | ||
| Q2 25 | $-309.0M | $-386.6M | ||
| Q3 24 | — | $198.1M | ||
| Q2 24 | $643.0M | — | ||
| Q2 23 | $-154.0M | — | ||
| Q2 22 | $842.0M | — |
| Q3 25 | — | — | ||
| Q2 25 | 65.0% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 63.8% | — | ||
| Q2 23 | 72.3% | — | ||
| Q2 22 | 72.7% | — |
| Q3 25 | — | -3.1% | ||
| Q2 25 | 62.7% | -192.1% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | 61.9% | — | ||
| Q2 23 | 69.1% | — | ||
| Q2 22 | 69.1% | — |
| Q3 25 | — | -1.9% | ||
| Q2 25 | -35.7% | -148.2% | ||
| Q3 24 | — | 15.9% | ||
| Q2 24 | 70.8% | — | ||
| Q2 23 | -28.6% | — | ||
| Q2 22 | 175.8% | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.2B | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.2B | — |
| Total Assets | $23.9B | — |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | — | ||
| Q2 25 | $1.2B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $466.0M | — | ||
| Q2 23 | $356.0M | — | ||
| Q2 22 | $512.0M | — |
| Q3 25 | — | — | ||
| Q2 25 | $2.2B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $3.5B | — | ||
| Q2 23 | $-764.0M | — | ||
| Q2 22 | $-1.1B | — |
| Q3 25 | — | — | ||
| Q2 25 | $23.9B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $23.7B | — | ||
| Q2 23 | $11.0B | — | ||
| Q2 22 | $10.0B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $478.0M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | — | ||
| Q2 25 | $478.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $511.0M | — | ||
| Q2 23 | $265.0M | — | ||
| Q2 22 | $232.0M | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.79× | — | ||
| Q2 23 | — | — | ||
| Q2 22 | 0.28× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
